Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Technology Segment
1.1.1.2. Application Segment
1.1.1.3. Cancer Type Segment
1.1.1.4. Function Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective – 1
1.4.2. Objective – 2
1.4.3. Objective – 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Next-generation Cancer Diagnostics Market: Executive Summary
2.1. Market Snapshot
2.2. Technology and Application Snapshot
2.3. Cancer Type and Function Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Next-generation Cancer Diagnostics Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Exponentially decreasing cost of genetic sequencing
3.4.2. Development of cluster chip technology and potential applications of CTC in cancer management
3.4.3. Rising demand for preventive medicine & companion diagnostics
3.4.4. Growing cancer incidence
3.5. Market Restraint Analysis
3.5.1. Requirement of expensive laboratory set-up for implementation of novel tests
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Pipeline Analysis
Chapter 4. Next-generation Cancer Diagnostics Market: Technology Estimates & Trend Analysis
4.1. Next-generation Cancer Diagnostics Market: Technology Movement Analysis
4.2. Next-generation Sequencing
4.2.1. Next-generation Sequencing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.3. qPCR & Multiplexing
4.3.1. qPCR & Multiplexing Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.4. LOAC & RT-PCR
4.4.1. LOAC & RT-PCR Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.5. Protein Microarrays
4.5.1. Protein Microarrays Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.6. DNA Microarrays
4.6.1. DNA Microarrays Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 5. Next-generation Cancer Diagnostics Market: Application Estimates & Trend Analysis
5.1. Next-generation Cancer Diagnostics Market: Application Movement Analysis
5.2. Biomarker Development
5.2.1. Biomarker Development Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
5.3. CTC Analysis
5.3.1. CTC Analysis Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
5.4. Proteomic Analysis
5.4.1. Proteomic Analysis Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
5.5. Epigenetic Analysis
5.5.1. Epigenetic Analysis Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
5.6. Genetic Analysis
5.6.1. Genetic Analysis Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 6. Next-generation Cancer Diagnostics Market: Cancer Type Estimates & Trend Analysis
6.1. Next-generation Cancer Diagnostics Market: Cancer Type Movement Analysis
6.2. Lung Cancer
6.2.1. Lung Cancer Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
6.3. Breast Cancer
6.3.1. Breast Cancer Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
6.4. Colorectal Cancer
6.4.1. Colorectal Cancer Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
6.5. Cervical Cancer
6.5.1. Cervical Cancer Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
6.6. Others
6.6.1. Others Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 7. Next-generation Cancer Diagnostics Market: Function Estimates & Trend Analysis
7.1. Next-generation Cancer Diagnostics Market: Cancer Type Movement Analysis
7.2. Therapeutic Monitoring
7.2.1. Therapeutic Monitoring Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
7.3. Companion Diagnostics
7.3.1. Companion Diagnostics Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
7.4. Prognostics
7.4.1. Prognostics Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
7.5. Cancer Screening
7.5.1. Cancer Screening Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
7.6. Risk Analysis
7.6.1. Risk Analysis Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 8. Next-generation Cancer Diagnostics Market: Regional Business Analysis
8.1. Regional Market Snapshot
8.2. North America
8.2.1. North America Next-generation Cancer Diagnostics Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.2.2.2. Key Country Dynamics
8.2.2.3. Regulatory Framework
8.2.2.4. Reimbursement Scenario
8.2.2.5. Competitive Scenario
8.2.3. CANADA
8.2.3.1. Canada Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.2.3.2. Key Country Dynamics
8.2.3.3. Regulatory Framework
8.2.3.4. Reimbursement Scenario
8.2.3.5. Competitive Scenario
8.3. Europe
8.3.1. Europe Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.3.2. UK
8.3.2.1. UK Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.3.2.2. Key Country Dynamics
8.3.2.3. Regulatory Framework
8.3.2.4. Reimbursement Scenario
8.3.2.5. Competitive Scenario
8.3.3. GERMANY
8.3.3.1. Germany Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.3.3.2. Key Country Dynamics
8.3.3.3. Regulatory Framework
8.3.3.4. Reimbursement Scenario
8.3.3.5. Competitive Scenario
8.3.4. SPAIN
8.3.4.1. Spain Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.3.4.2. Key Country Dynamics
8.3.4.3. Regulatory Framework
8.3.4.4. Reimbursement Scenario
8.3.4.5. Competitive Scenario
8.3.5. FRANCE
8.3.5.1. France Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.3.5.2. Key Country Dynamics
8.3.5.3. Regulatory Framework
8.3.5.4. Reimbursement Scenario
8.3.5.5. Competitive Scenario
8.3.6. ITALY
8.3.6.1. Italy Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.3.6.2. Key Country Dynamics
8.3.6.3. Regulatory Framework
8.3.6.4. Reimbursement Scenario
8.3.6.5. Competitive Scenario
8.3.7. DENMARK
8.3.7.1. Denmark Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.3.7.2. Key Country Dynamics
8.3.7.3. Regulatory Framework
8.3.7.4. Reimbursement Scenario
8.3.7.5. Competitive Scenario
8.3.8. SWEDEN
8.3.8.1. Sweden Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.3.8.2. Key Country Dynamics
8.3.8.3. Regulatory Framework
8.3.8.4. Reimbursement Scenario
8.3.8.5. Competitive Scenario
8.3.9. NORWAY
8.3.9.1. Norway Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.3.9.2. Key Country Dynamics
8.3.9.3. Regulatory Framework
8.3.9.4. Reimbursement Scenario
8.3.9.5. Competitive Scenario
8.4. Asia Pacific
8.4.1. Asia-Pacific Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.4.2. JAPAN
8.4.2.1. Japan Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.4.2.2. Key Country Dynamics
8.4.2.3. Regulatory Framework
8.4.2.4. Reimbursement Scenario
8.4.2.5. Competitive Scenario
8.4.3. CHINA
8.4.3.1. China Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.4.3.2. Key Country Dynamics
8.4.3.3. Regulatory Framework
8.4.3.4. Reimbursement Scenario
8.4.3.5. Competitive Scenario
8.4.4. INDIA
8.4.4.1. India Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.4.4.2. Key Country Dynamics
8.4.4.3. Regulatory Framework
8.4.4.4. Reimbursement Scenario
8.4.4.5. Competitive Scenario
8.4.5. SOUTH KOREA
8.4.5.1. South Korea Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.4.5.2. Key Country Dynamics
8.4.5.3. Regulatory Framework
8.4.5.4. Reimbursement Scenario
8.4.5.5. Competitive Scenario
8.4.6. THAILAND
8.4.6.1. Thailand Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.4.6.2. Key Country Dynamics
8.4.6.3. Regulatory Framework
8.4.6.4. Reimbursement Scenario
8.4.6.5. Competitive Scenario
8.4.7. AUSTRALIA
8.4.7.1. Australia Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.4.7.2. Key Country Dynamics
8.4.7.3. Regulatory Framework
8.4.7.4. Reimbursement Scenario
8.4.7.5. Competitive Scenario
8.5. Latin America
8.5.1. Latin America Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.5.2. BRAZIL
8.5.2.1. Brazil Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.5.2.2. Key Country Dynamics
8.5.2.3. Regulatory Framework
8.5.2.4. Reimbursement Scenario
8.5.2.5. Competitive Scenario
8.5.3. MEXICO
8.5.3.1. Mexico Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.5.3.2. Key Country Dynamics
8.5.3.3. Regulatory Framework
8.5.3.4. Reimbursement Scenario
8.5.3.5. Competitive Scenario
8.5.4. ARGENTINA
8.5.4.1. Argentina Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.5.4.2. Key Country Dynamics
8.5.4.3. Regulatory Framework
8.5.4.4. Reimbursement Scenario
8.5.4.5. Competitive Scenario
8.6. MEA
8.6.1. MEA Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.6.2. SOUTH AFRICA
8.6.2.1. South Africa Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.6.2.2. Key Country Dynamics
8.6.2.3. Regulatory Framework
8.6.2.4. Reimbursement Scenario
8.6.2.5. Competitive Scenario
8.6.3. SAUDI ARABIA
8.6.3.1. Saudi Arabia Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.6.3.2. Key Country Dynamics
8.6.3.3. Regulatory Framework
8.6.3.4. Reimbursement Scenario
8.6.3.5. Competitive Scenario
8.6.4. UAE
8.6.4.1. UAE Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.6.4.2. Key Country Dynamics
8.6.4.3. Regulatory Framework
8.6.4.4. Reimbursement Scenario
8.6.4.5. Competitive Scenario
8.6.5. KUWAIT
8.6.5.1. Kuwait Next-generation Cancer Diagnostics Market, 2018 – 2030 (USD Million)
8.6.5.2. Key Country Dynamics
8.6.5.3. Regulatory Framework
8.6.5.4. Reimbursement Scenario
8.6.5.5. Competitive Scenario
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.2.1. New Product Launch
9.2.2. Partnerships
9.2.3. Acquisition
9.2.4. Collaboration
9.2.5. Funding
9.3. Key Company Market Share Analysis, 2022
9.4. Company Heat Map Analysis
9.5. Company Profiles
9.5.1. JANSSEN PHARMACEUTICALS, INC.
9.5.1.1. Company Overview
9.5.1.2. Financial Performance
9.5.1.3. Product Benchmarking
9.5.1.4. Strategic Initiatives
9.5.2. NOVARTIS AG
9.5.2.1. Company Overview
9.5.2.2. Financial Performance
9.5.2.3. Product Benchmarking
9.5.2.4. Strategic Initiatives
9.5.3. F. HOFFMANN-LA ROCHE LTD
9.5.3.1. Company Overview
9.5.3.2. Financial Performance
9.5.3.3. Product Benchmarking
9.5.3.4. Strategic Initiatives
9.5.4. KONINKLIJKE PHILIPS N.V.
9.5.4.1. Company Overview
9.5.4.2. Financial Performance
9.5.4.3. Product Benchmarking
9.5.4.4. Strategic Initiatives
9.5.5. ABBOTT
9.5.5.1. Company Overview
9.5.5.2. Financial Performance
9.5.5.3. Product Benchmarking
9.5.6. GE HEALTHCARE
9.5.6.1. Company Overview
9.5.6.2. Financial Performance
9.5.6.3. Product Benchmarking
9.5.6.4. Strategic Initiatives
9.5.7. THERMO FISHER SCIENTIFIC, INC.
9.5.7.1. Company Overview
9.5.7.2. Financial Performance
9.5.7.3. Product Benchmarking
9.5.7.4. Strategic Initiatives
9.5.8. AGILENT TECHNOLOGIES, INC. (DAKO)
9.5.8.1. Company Overview
9.5.8.2. Financial Performance
9.5.8.3. Product Benchmarking
9.5.8.4. Strategic Initiatives
9.5.9. ILLUMINA, INC.
9.5.9.1. Company Overview
9.5.9.2. Financial Performance
9.5.9.3. Product Benchmarking
9.5.9.4. Strategic Initiatives
9.5.10. QIAGEN
9.5.10.1. Company Overview
9.5.10.2. Financial Performance
9.5.10.3. Product Benchmarking
9.5.10.4. Strategic Initiatives
9.5.11. CEPHEID
9.5.11.1. Company Overview
9.5.11.2. Financial Performance
9.5.11.3. Product Benchmarking
9.5.11.4. Strategic Initiatives
9.5.12. OPKO HEALTH, INC.
9.5.12.1. Company Overview
9.5.12.2. Financial Performance
9.5.12.3. Product Benchmarking
9.5.12.4. Strategic Initiatives
9.5.13. HOLOGIC, INC (GEN-PROBE)
9.5.13.1. Company Overview
9.5.13.2. Financial Performance
9.5.13.3. Product Benchmarking
9.5.13.4. Strategic Initiatives
9.5.14. PERKINELMER INC.
9.5.14.1. Company Overview
9.5.14.2. Financial Performance
9.5.14.3. Product Benchmarking
9.5.14.4. Strategic Initiatives
9.5.15. SYSMEX
9.5.15.1. Company Overview
9.5.15.2. Financial Performance
9.5.15.3. Product Benchmarking
9.5.15.4. Strategic Initiatives
9.5.16. MYRIAD GENETICS, INC.
9.5.16.1. Company Overview
9.5.16.2. Financial Performance
9.5.16.3. Product Benchmarking
9.5.16.4. Strategic Initiatives
9.5.17. ALMAC GROUP
9.5.17.1. Company Overview
9.5.17.2. Financial Performance
9.5.17.3. Product Benchmarking
9.5.17.4. Strategic Initiatives
9.5.18. EXOSOME DIAGNOSTICS, INC.
9.5.18.1. Company Overview
9.5.18.2. Financial Performance
9.5.18.3. Product Benchmarking
9.5.18.4. Strategic Initiatives
9.5.19. GENOMIC HEALTH, INC.
9.5.19.1. Company Overview
9.5.19.2. Financial Performance
9.5.19.3. Product Benchmarking
9.5.19.4. Strategic Initiatives
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America next-generation cancer diagnostics market, by country, 2018 - 2030 (USD Million)
Table 4 North America next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 5 North America next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 6 North America next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 7 North America next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 8 U.S next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 9 U.S next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 10 U.S next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 11 U.S. next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 12 Canada next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 13 Canada next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 14 Canada next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 15 Canada next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 16 Europe next-generation cancer diagnostics market, by country, 2018 - 2030 (USD Million)
Table 17 Europe next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 18 Europe next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 19 Europe next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 20 Europe next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 21 UK next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 22 UK next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 23 UK next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 24 UK next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 25 Germany next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 26 Germany next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 27 Germany next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 28 Germany next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 29 France next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 30 France next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 31 France next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 32 France next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 33 Italy next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 34 Italy next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 35 Italy next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 36 Italy next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 37 Spain next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 38 Spain next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 39 Spain next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 40 Spain next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 41 Denmark next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 42 Denmark next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 43 Denmark next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 44 Denmark next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 45 Sweden next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 46 Sweden next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 47 Sweden next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 48 Sweden next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 49 Norway next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 50 Norway next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 51 Norway next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 52 Norway next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 53 Asia Pacific next-generation cancer diagnostics market, by country, 2018 - 2030 (USD Million)
Table 54 Asia Pacific next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 55 Asia Pacific next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 56 Asia Pacific next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 57 Asia Pacific next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 58 China next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 59 China next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 60 China next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 61 China next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 62 Japan next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 63 Japan next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 64 Japan next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 65 Japan next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 66 India next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 67 India next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 68 India next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 69 India next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 70 South Korea next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 71 South Korea next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 72 South Korea next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 73 South Korea next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 74 Australia next-generation cancer diagnostics market, by technology 2018 - 2030 (USD Million)
Table 75 Australia next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 76 Australia next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 77 Australia next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 78 Thailand next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 79 Thailand next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 80 Thailand next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 81 Thailand next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 82 Latin America next-generation cancer diagnostics market, by country, 2018 - 2030 (USD Million)
Table 83 Latin America next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 84 Latin America next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 85 Latin America next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 86 Latin America next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 87 Brazil next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 88 Brazil next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 89 Brazil next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 90 Brazil next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 91 Mexico next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 92 Mexico next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 93 Mexico next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 94 Mexico next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 95 Argentina next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 96 Argentina next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 97 Argentina next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 98 Argentina next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 99 Middle East & Africa next-generation cancer diagnostics market, by country, 2018 - 2030 (USD Million)
Table 100 Middle East & Africa next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 101 Middle East & Africa next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 102 Middle East & Africa next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 103 Middle East & Africa next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 104 South Africa next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 105 South Africa next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 106 South Africa next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 107 South Africa next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 111 Saudi Arabia next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 112 UAE next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 113 UAE next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 114 UAE next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 115 UAE next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
Table 116 Kuwait next-generation cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 117 Kuwait next-generation cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 118 Kuwait next-generation cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 119 Kuwait next-generation cancer diagnostics market, by function, 2018 - 2030 (USD Million)
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
